Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
United States | Publication | februari 2022
Norton Rose Fulbright lawyers Roger Kuan and Jason Novak contributed several chapters to Digital Health 2022 International Comparative Legal Guide, published by GLG, which is a leading global platform for legal reference, analysis and news. Kuan also served as a contributing editor for the publication.
Authors: Roger Kuan, Norton Rose Fulbright and David Wallace, Johnson & Johnson
As an introduction into digital health, Kuan expands on the digital technologies in healthcare including healthcare IT, data use, data sharing, intellectual property, commercial agreements, AI and machine learning and liability and the acceleration transformation that was experienced during the pandemic.
Authors: Jason Novak, Norton Rose Fulbright and René Quashie, Consumer Technology Association
Novak explores Digital Therapeutics (DTx), an innovative subset of digital health that has quickly become a new platform for addressing treatment, management and prevention of various disease, as well as any legal and regulatory issues that may arise.
Authors: Roger Kuan and Jason Novak, Norton Rose Fulbright
In this chapter, Kuan and Novak provide answers to key questions regarding digital health and emerging technologies.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
After a lacklustre finish to 2022 when compared to the vintage year for M&A that was 2021, dealmakers expected 2023 to see the market continue to cool in most sectors, in response to the economic headwinds of rising inflation (with its corresponding impact on financing costs), declining market valuations, tightening regulatory scrutiny and increasing geopolitical tensions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023